Effects of an extract obtained from fruits of Euterpe oleracea Mart. in the components of metabolic syndrome induced in C57BL/6J mice fed a high-fat diet

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 6, 2010, Pages 619-626

  Braz De Oliveira, Paola Raquel ^a   Da Costa, Cristiane Aguiar ^a   De Bem, Graziele Freitas ^a   Reis Marins De Cavalho, Lenize Costa ^a   Vieira De Souza, Marcelo Augusto ^a   De Lemos Neto, Miguel ^a   Da Cunha Sousa, Pergentino José ^b   De Moura, Roberto Soares ^a   Resende, Angela Castro ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Acx ?; Antioxidant; Euterpe oleracea mart.; Metabolic syndrome; Nitric oxide

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; EUTERPE OLERACEA EXTRACT; GLUCOSE; GLYCERYL TRINITRATE; MALONALDEHYDE; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARECACEAE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; EUTERPE OLERACEA; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MESENTERY BLOOD FLOW; METABOLIC SYNDROME X; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLANT SEED; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ANIMALS; ARECACEAE; DIETARY FATS; FRUIT; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; OBESITY; PLANT EXTRACTS;

EID: 78751650152     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181f78da4     Document Type: Article

References (46)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:415-428.
2. Dohadwala MM, Vita JA. Grapes and cardiovascular disease. J Nutr. 2009;139:S1788-S1793.
3. Bobbio FO, Druzian JI, Abrão PA, et al. Identificaĉxão e quantificaĉxão das antocianinas do fruto do aĉa?́zeiro (Euterpe oleracea Mart.). Ciěnc Tecnol Aliment. 2000;20:388-390.
4. Pozo-Isfran DD, Brenes CH, Talcoot ST. Phytochemical composition and pigment stability of Aĉaí (Euterpe oleracea Mart.). J Agric Food Chem. 2004;52:1539-1545.
5. Gallori S, Bilia AR, Bergonzi MC, et al. Polyphenolic constituents of fruit pulp of Euterpe oleracea Mart. (Aĉxa?́ palm). Chromatographia. 2004;59: 739-743.
6. Mertens-Talcott SU, Rios J, Jilma-Stohlawetz P, et al. Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin- rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. J Agric Food Chem. 2008;56:7796-7802.
7. Stoclet JC, Chataigneau T, Ndiaye M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500:299-313.
8. Seifried HE, Anderson DE, Fisher EI, et al. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem. 2007;18:567-579.
9. Fitzpatrick DF, Fleming RC, Bing B, et al. Isolation and characterization of endothelium-dependent vasorelaxation compounds from grape stones. J Agric Food Chem. 2000;48:6384-6390.
10. Soares de Moura R, Miranda DZ, Pinto ACA, et al. Mechanism of the endothelium-dependent vasodilation and antihypertensive effect of brazilian red wine. J Cardiovasc Pharmacol. 2004;44:302-309.
11. Rocha APM, Carvalho LCRM, Souza MAV, et al. Endotheliumdependent vasodilator effect of Euterpe oleracea Mart. (Aĉaí) extracts in mesenteric vascular bed of the rat. Vasc Pharmacol. 2007;46:97-104.
12. Rocha APM, Resende AC, Souza MAV, et al. Antihypertensive effects and antioxidant action of a hydro-alcoholic extract obtained from fruits of Euterpe oleracea Mart. (Aĉa?́). J Pharmacol Toxicol Methods. 2008;3: 435-448.
13. Lichtenthaler R, Rodrigues RB, Maia JG, et al. Total oxidant scavenging capacities of Euterpe oleracea Mart. (Aĉai) fruits. Int J Food Sci Nutr. 2005;56:53-64.
14. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16:144-158.
15. Mundy AL, Haas E, Bhattacharya I, et al. Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res. 2007;73:368-375.
16. Molnar J, Yu S, Mzhavia N, et al. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res. 2005;96:1178-1184.
17. Tao R, Ye F, He Y, et al. Improvement of high-fat-diet-induced metabolic syndrome by a compound from Balanophora polyandra Griff in mice. Eur J Pharmacol. 2009;616:328-333.
18. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993; 123:1939-1951.
19. McGregor DD. The effect of sympathetic nerve stimulation on vasoconstrictor response in perfused mesenteric blood vessels of the rat. J Physiol. 1965;177:21-30.
20. Draper HH, Squires EJ, Mahmoodi H, et al. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med. 1993;15:353-363.
21. Gogia A, Agarwal PK. Metabolic syndrome. Indian J Med Sci. 2006;60: 72-81.
22. Cong WN, Tao RY, Tian JY, et al. The establishment of a novel nonalcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Life Sci. 2008;82:983-990.
23. Gallou-Kabani C, Vigé A, Gross MS, et al. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity. 2007;15:1996-2005.
24. Choi JS, Koh IU, Jung MH, et al. Effects of three different conjugated linoleic acid preparations on insulin signalling, fat oxidation and mitochondrial function in rats fed a high-fat diet. Br J Nutr. 2007;98:264-275.
25. Matsuzawa-Nagata N, Takamura T, Ando H, et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism. 2008;57:1071-1077.
26. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
27. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
28. Fortuño A, Bidegain J, San José G, et al. Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients. J Hypertens. 2009;27:1420-1430.
29. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84:705-712.
30. Williams TD, Chambers JB, Roberts LM, et al. Diet-induced obesity and cardiovascular regulation in C57BL/6J mice. Clin Exp Pharmacol Physiol. 2003;30:769-778.
31. Tsuda T. Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. J Agric Food Chem. 2008;56:642-646.
32. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270: 26746-26749.
33. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221: 286-289.
34. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
35. Yoshikawa M, Shimoda H, Nishida N, et al. Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats. J Nutr. 2002;132:1819-1824.
36. Devaskar SU, Thamotharan M. Metabolic programming in the pathogenesis of insulin resistance. Rev Endocr Metab Disord. 2007;8: 105-113.
37. Godoy-Matos A, Carraro L, Vieira A, et al. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab. 2005;90:1460-1465.
38. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29: 1130-1139.
39. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17:4-12.
40. Dandona P, Aljada A, Chaudhuri A, et al. Between obesity, diabetes, and inflammation metabolic syndrome: a comprehensive perspective based on interactions. Circulation. 2005;111: 1448-1454.
41. Evans JL. Antioxidants: do they have a role in the treatment of insulin resistance? Indian J Med Res. 2007;125:355-372.
42. Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol. 1998;274:E692-E699.
43. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol. 1997;82:359-363.
44. Lira VA, Soltow QA, Long JH, et al. Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. Am J Physiol Endocrinol Metab. 2007;293:E1062-E1068.
45. Frankel EN, Kanmer J, German JB, et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993; 341:454-457.
46. Lerman LO, Chade AR, Sica V, et al. Animals models of hypertension: an overview. J Lab Clin Med. 2005;146:160-173.